Molecular Anatomy of 2009 Influenza Virus A (H1N1)

Influenza A viruses are a major cause of morbidity and mortality worldwide and affect large segments of the population every year. The nature of their genome, formed by eight segments of single-stranded RNA, favors the constant evolution of the virus by two main mechanisms: the accumulation of singl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of medical research 2009-11, Vol.40 (8), p.643-654
Hauptverfasser: Arias, Carlos F, Escalera-Zamudio, Marina, de los Dolores Soto-Del Río, María, Georgina Cobián-Güemes, Ana, Isa, Pavel, López, Susana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 654
container_issue 8
container_start_page 643
container_title Archives of medical research
container_volume 40
creator Arias, Carlos F
Escalera-Zamudio, Marina
de los Dolores Soto-Del Río, María
Georgina Cobián-Güemes, Ana
Isa, Pavel
López, Susana
description Influenza A viruses are a major cause of morbidity and mortality worldwide and affect large segments of the population every year. The nature of their genome, formed by eight segments of single-stranded RNA, favors the constant evolution of the virus by two main mechanisms: the accumulation of single nucleotide mutations in the viral genes introduced by an error-prone viral RNA polymerase and the reassortment of genes between two strains of different origin. The viral genome encodes 11 proteins. Most have been shown to play a role in shaping the virulence scenario of influenza A viruses, including the adaptation of infection and transmission into new host species, the ability to modulate the host immune response, and the capacity to replicate efficiently at low temperature. On the surface of the virus particles there are two principal polypeptides, the hemagglutinin (HA) and the neuraminidase (NA), which are the target for the neutralizing antibodies immune response. There are 16 HA and 9 NA different subtypes in the influenza A virus that circulate in humans and animals. When a virus strain with a new HA or NA subtype appears in the human population by genetic reassortment, it usually causes a pandemic because there is no preexisting immunity against the new virus. This was the case for the three pandemics that occurred during the last century (1918, 1957, and 1968) and also for the first pandemic of the 21st century, caused by the currently circulating A (H1N1) 2009 virus, which was generated by gene reassortment between a virus present in pigs of North America and a virus that circulates in the swine population of Euroasia.
doi_str_mv 10.1016/j.arcmed.2009.10.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_744619693</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0188440909001969</els_id><sourcerecordid>733255182</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-68f1707e5d4e560458b84f9668fdd42c92386434ceb673943bc474305b23d2523</originalsourceid><addsrcrecordid>eNqFkU9P20AQxVcVqITQb1Ah32gPTmd3Z__4ghRFLSCF9lDa68pej6UNjg27MVL66WsTuHBBcxjpzZs30m8Y-8xhwYHrb5tFGf2W6oUAKEZpAWA-sBm3RuYKrTliM-DW5ohQnLDTlDYAYFGbj-xEgAQUis-YuO1b8kNbxmzZlbt-u8_6Jpsis5uuaQfq_pXZ3xCHlC2zL9f8J_96xo6bsk306aXP2Z8f3-9W1_n619XNarnOveK4y7VtuAFDqkZSGlDZymJT6FGvaxS-ENJqlOip0kYWKCuPBiWoSshaKCHn7OKQ-xD7x4HSzm1D8tS2ZUf9kJxB1LzQhXzfKaVQitspEw9OH_uUIjXuIYZtGfeOg5uwuo07YHUTg0kdsY5r5y8HhmqavS69chwNlwcDjUCeAkWXfKDOUx0i-Z2r-_DehbcBvg1d8GV7T3tKm36I3QjbcZeEA_d7eu302bHgGcJ_Q7GZ-Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733255182</pqid></control><display><type>article</type><title>Molecular Anatomy of 2009 Influenza Virus A (H1N1)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Arias, Carlos F ; Escalera-Zamudio, Marina ; de los Dolores Soto-Del Río, María ; Georgina Cobián-Güemes, Ana ; Isa, Pavel ; López, Susana</creator><creatorcontrib>Arias, Carlos F ; Escalera-Zamudio, Marina ; de los Dolores Soto-Del Río, María ; Georgina Cobián-Güemes, Ana ; Isa, Pavel ; López, Susana</creatorcontrib><description>Influenza A viruses are a major cause of morbidity and mortality worldwide and affect large segments of the population every year. The nature of their genome, formed by eight segments of single-stranded RNA, favors the constant evolution of the virus by two main mechanisms: the accumulation of single nucleotide mutations in the viral genes introduced by an error-prone viral RNA polymerase and the reassortment of genes between two strains of different origin. The viral genome encodes 11 proteins. Most have been shown to play a role in shaping the virulence scenario of influenza A viruses, including the adaptation of infection and transmission into new host species, the ability to modulate the host immune response, and the capacity to replicate efficiently at low temperature. On the surface of the virus particles there are two principal polypeptides, the hemagglutinin (HA) and the neuraminidase (NA), which are the target for the neutralizing antibodies immune response. There are 16 HA and 9 NA different subtypes in the influenza A virus that circulate in humans and animals. When a virus strain with a new HA or NA subtype appears in the human population by genetic reassortment, it usually causes a pandemic because there is no preexisting immunity against the new virus. This was the case for the three pandemics that occurred during the last century (1918, 1957, and 1968) and also for the first pandemic of the 21st century, caused by the currently circulating A (H1N1) 2009 virus, which was generated by gene reassortment between a virus present in pigs of North America and a virus that circulates in the swine population of Euroasia.</description><identifier>ISSN: 0188-4409</identifier><identifier>EISSN: 1873-5487</identifier><identifier>DOI: 10.1016/j.arcmed.2009.10.007</identifier><identifier>PMID: 20304251</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Antibodies, Neutralizing - immunology ; Antibodies, Viral - immunology ; Antiviral Agents - therapeutic use ; Biology ; Evolution, Molecular ; Galactose - chemistry ; Galactose - metabolism ; Genes, Viral ; Hemagglutinin Glycoproteins, Influenza Virus - genetics ; Hemagglutinin Glycoproteins, Influenza Virus - immunology ; Humans ; Influenza ; Influenza A virus ; Influenza A Virus, H1N1 Subtype - classification ; Influenza A Virus, H1N1 Subtype - genetics ; Influenza A Virus, H1N1 Subtype - immunology ; Influenza A Virus, H1N1 Subtype - physiology ; Influenza, Human - drug therapy ; Influenza, Human - virology ; Internal Medicine ; Neuraminidase - antagonists &amp; inhibitors ; Neuraminidase - genetics ; Neuraminidase - immunology ; Pandemics ; Pathogenesis ; Phylogeny ; Receptors, Virus - metabolism ; Sialic Acids - chemistry ; Sialic Acids - metabolism ; Viral Proteins - genetics ; Viral Proteins - metabolism ; Viral Tropism ; Virulence ; Virus Replication - physiology</subject><ispartof>Archives of medical research, 2009-11, Vol.40 (8), p.643-654</ispartof><rights>IMSS</rights><rights>2009 IMSS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c514t-68f1707e5d4e560458b84f9668fdd42c92386434ceb673943bc474305b23d2523</citedby><cites>FETCH-LOGICAL-c514t-68f1707e5d4e560458b84f9668fdd42c92386434ceb673943bc474305b23d2523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.arcmed.2009.10.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20304251$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arias, Carlos F</creatorcontrib><creatorcontrib>Escalera-Zamudio, Marina</creatorcontrib><creatorcontrib>de los Dolores Soto-Del Río, María</creatorcontrib><creatorcontrib>Georgina Cobián-Güemes, Ana</creatorcontrib><creatorcontrib>Isa, Pavel</creatorcontrib><creatorcontrib>López, Susana</creatorcontrib><title>Molecular Anatomy of 2009 Influenza Virus A (H1N1)</title><title>Archives of medical research</title><addtitle>Arch Med Res</addtitle><description>Influenza A viruses are a major cause of morbidity and mortality worldwide and affect large segments of the population every year. The nature of their genome, formed by eight segments of single-stranded RNA, favors the constant evolution of the virus by two main mechanisms: the accumulation of single nucleotide mutations in the viral genes introduced by an error-prone viral RNA polymerase and the reassortment of genes between two strains of different origin. The viral genome encodes 11 proteins. Most have been shown to play a role in shaping the virulence scenario of influenza A viruses, including the adaptation of infection and transmission into new host species, the ability to modulate the host immune response, and the capacity to replicate efficiently at low temperature. On the surface of the virus particles there are two principal polypeptides, the hemagglutinin (HA) and the neuraminidase (NA), which are the target for the neutralizing antibodies immune response. There are 16 HA and 9 NA different subtypes in the influenza A virus that circulate in humans and animals. When a virus strain with a new HA or NA subtype appears in the human population by genetic reassortment, it usually causes a pandemic because there is no preexisting immunity against the new virus. This was the case for the three pandemics that occurred during the last century (1918, 1957, and 1968) and also for the first pandemic of the 21st century, caused by the currently circulating A (H1N1) 2009 virus, which was generated by gene reassortment between a virus present in pigs of North America and a virus that circulates in the swine population of Euroasia.</description><subject>Animals</subject><subject>Antibodies, Neutralizing - immunology</subject><subject>Antibodies, Viral - immunology</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Biology</subject><subject>Evolution, Molecular</subject><subject>Galactose - chemistry</subject><subject>Galactose - metabolism</subject><subject>Genes, Viral</subject><subject>Hemagglutinin Glycoproteins, Influenza Virus - genetics</subject><subject>Hemagglutinin Glycoproteins, Influenza Virus - immunology</subject><subject>Humans</subject><subject>Influenza</subject><subject>Influenza A virus</subject><subject>Influenza A Virus, H1N1 Subtype - classification</subject><subject>Influenza A Virus, H1N1 Subtype - genetics</subject><subject>Influenza A Virus, H1N1 Subtype - immunology</subject><subject>Influenza A Virus, H1N1 Subtype - physiology</subject><subject>Influenza, Human - drug therapy</subject><subject>Influenza, Human - virology</subject><subject>Internal Medicine</subject><subject>Neuraminidase - antagonists &amp; inhibitors</subject><subject>Neuraminidase - genetics</subject><subject>Neuraminidase - immunology</subject><subject>Pandemics</subject><subject>Pathogenesis</subject><subject>Phylogeny</subject><subject>Receptors, Virus - metabolism</subject><subject>Sialic Acids - chemistry</subject><subject>Sialic Acids - metabolism</subject><subject>Viral Proteins - genetics</subject><subject>Viral Proteins - metabolism</subject><subject>Viral Tropism</subject><subject>Virulence</subject><subject>Virus Replication - physiology</subject><issn>0188-4409</issn><issn>1873-5487</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9P20AQxVcVqITQb1Ah32gPTmd3Z__4ghRFLSCF9lDa68pej6UNjg27MVL66WsTuHBBcxjpzZs30m8Y-8xhwYHrb5tFGf2W6oUAKEZpAWA-sBm3RuYKrTliM-DW5ohQnLDTlDYAYFGbj-xEgAQUis-YuO1b8kNbxmzZlbt-u8_6Jpsis5uuaQfq_pXZ3xCHlC2zL9f8J_96xo6bsk306aXP2Z8f3-9W1_n619XNarnOveK4y7VtuAFDqkZSGlDZymJT6FGvaxS-ENJqlOip0kYWKCuPBiWoSshaKCHn7OKQ-xD7x4HSzm1D8tS2ZUf9kJxB1LzQhXzfKaVQitspEw9OH_uUIjXuIYZtGfeOg5uwuo07YHUTg0kdsY5r5y8HhmqavS69chwNlwcDjUCeAkWXfKDOUx0i-Z2r-_DehbcBvg1d8GV7T3tKm36I3QjbcZeEA_d7eu302bHgGcJ_Q7GZ-Q</recordid><startdate>20091101</startdate><enddate>20091101</enddate><creator>Arias, Carlos F</creator><creator>Escalera-Zamudio, Marina</creator><creator>de los Dolores Soto-Del Río, María</creator><creator>Georgina Cobián-Güemes, Ana</creator><creator>Isa, Pavel</creator><creator>López, Susana</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20091101</creationdate><title>Molecular Anatomy of 2009 Influenza Virus A (H1N1)</title><author>Arias, Carlos F ; Escalera-Zamudio, Marina ; de los Dolores Soto-Del Río, María ; Georgina Cobián-Güemes, Ana ; Isa, Pavel ; López, Susana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-68f1707e5d4e560458b84f9668fdd42c92386434ceb673943bc474305b23d2523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Antibodies, Neutralizing - immunology</topic><topic>Antibodies, Viral - immunology</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Biology</topic><topic>Evolution, Molecular</topic><topic>Galactose - chemistry</topic><topic>Galactose - metabolism</topic><topic>Genes, Viral</topic><topic>Hemagglutinin Glycoproteins, Influenza Virus - genetics</topic><topic>Hemagglutinin Glycoproteins, Influenza Virus - immunology</topic><topic>Humans</topic><topic>Influenza</topic><topic>Influenza A virus</topic><topic>Influenza A Virus, H1N1 Subtype - classification</topic><topic>Influenza A Virus, H1N1 Subtype - genetics</topic><topic>Influenza A Virus, H1N1 Subtype - immunology</topic><topic>Influenza A Virus, H1N1 Subtype - physiology</topic><topic>Influenza, Human - drug therapy</topic><topic>Influenza, Human - virology</topic><topic>Internal Medicine</topic><topic>Neuraminidase - antagonists &amp; inhibitors</topic><topic>Neuraminidase - genetics</topic><topic>Neuraminidase - immunology</topic><topic>Pandemics</topic><topic>Pathogenesis</topic><topic>Phylogeny</topic><topic>Receptors, Virus - metabolism</topic><topic>Sialic Acids - chemistry</topic><topic>Sialic Acids - metabolism</topic><topic>Viral Proteins - genetics</topic><topic>Viral Proteins - metabolism</topic><topic>Viral Tropism</topic><topic>Virulence</topic><topic>Virus Replication - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arias, Carlos F</creatorcontrib><creatorcontrib>Escalera-Zamudio, Marina</creatorcontrib><creatorcontrib>de los Dolores Soto-Del Río, María</creatorcontrib><creatorcontrib>Georgina Cobián-Güemes, Ana</creatorcontrib><creatorcontrib>Isa, Pavel</creatorcontrib><creatorcontrib>López, Susana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Archives of medical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arias, Carlos F</au><au>Escalera-Zamudio, Marina</au><au>de los Dolores Soto-Del Río, María</au><au>Georgina Cobián-Güemes, Ana</au><au>Isa, Pavel</au><au>López, Susana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular Anatomy of 2009 Influenza Virus A (H1N1)</atitle><jtitle>Archives of medical research</jtitle><addtitle>Arch Med Res</addtitle><date>2009-11-01</date><risdate>2009</risdate><volume>40</volume><issue>8</issue><spage>643</spage><epage>654</epage><pages>643-654</pages><issn>0188-4409</issn><eissn>1873-5487</eissn><abstract>Influenza A viruses are a major cause of morbidity and mortality worldwide and affect large segments of the population every year. The nature of their genome, formed by eight segments of single-stranded RNA, favors the constant evolution of the virus by two main mechanisms: the accumulation of single nucleotide mutations in the viral genes introduced by an error-prone viral RNA polymerase and the reassortment of genes between two strains of different origin. The viral genome encodes 11 proteins. Most have been shown to play a role in shaping the virulence scenario of influenza A viruses, including the adaptation of infection and transmission into new host species, the ability to modulate the host immune response, and the capacity to replicate efficiently at low temperature. On the surface of the virus particles there are two principal polypeptides, the hemagglutinin (HA) and the neuraminidase (NA), which are the target for the neutralizing antibodies immune response. There are 16 HA and 9 NA different subtypes in the influenza A virus that circulate in humans and animals. When a virus strain with a new HA or NA subtype appears in the human population by genetic reassortment, it usually causes a pandemic because there is no preexisting immunity against the new virus. This was the case for the three pandemics that occurred during the last century (1918, 1957, and 1968) and also for the first pandemic of the 21st century, caused by the currently circulating A (H1N1) 2009 virus, which was generated by gene reassortment between a virus present in pigs of North America and a virus that circulates in the swine population of Euroasia.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>20304251</pmid><doi>10.1016/j.arcmed.2009.10.007</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0188-4409
ispartof Archives of medical research, 2009-11, Vol.40 (8), p.643-654
issn 0188-4409
1873-5487
language eng
recordid cdi_proquest_miscellaneous_744619693
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Antibodies, Neutralizing - immunology
Antibodies, Viral - immunology
Antiviral Agents - therapeutic use
Biology
Evolution, Molecular
Galactose - chemistry
Galactose - metabolism
Genes, Viral
Hemagglutinin Glycoproteins, Influenza Virus - genetics
Hemagglutinin Glycoproteins, Influenza Virus - immunology
Humans
Influenza
Influenza A virus
Influenza A Virus, H1N1 Subtype - classification
Influenza A Virus, H1N1 Subtype - genetics
Influenza A Virus, H1N1 Subtype - immunology
Influenza A Virus, H1N1 Subtype - physiology
Influenza, Human - drug therapy
Influenza, Human - virology
Internal Medicine
Neuraminidase - antagonists & inhibitors
Neuraminidase - genetics
Neuraminidase - immunology
Pandemics
Pathogenesis
Phylogeny
Receptors, Virus - metabolism
Sialic Acids - chemistry
Sialic Acids - metabolism
Viral Proteins - genetics
Viral Proteins - metabolism
Viral Tropism
Virulence
Virus Replication - physiology
title Molecular Anatomy of 2009 Influenza Virus A (H1N1)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T14%3A50%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20Anatomy%20of%202009%20Influenza%20Virus%20A%20(H1N1)&rft.jtitle=Archives%20of%20medical%20research&rft.au=Arias,%20Carlos%20F&rft.date=2009-11-01&rft.volume=40&rft.issue=8&rft.spage=643&rft.epage=654&rft.pages=643-654&rft.issn=0188-4409&rft.eissn=1873-5487&rft_id=info:doi/10.1016/j.arcmed.2009.10.007&rft_dat=%3Cproquest_cross%3E733255182%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733255182&rft_id=info:pmid/20304251&rft_els_id=S0188440909001969&rfr_iscdi=true